Cerenia

Verify with FDA CVM →

63 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
16
Deaths Reported
2540.0%
Death Rate

Active Ingredients

Cerenia

Administration Routes

UnknownSubcutaneousOralOther

Species Affected

Dog 52
Cat 11

Most Affected Breeds

Domestic Shorthair 7
Dog (unknown) 6
Crossbred Canine/dog 5
Schnauzer - Miniature 4
Retriever - Labrador 4
Terrier - Yorkshire 3
Boxer (German Boxer) 3
Chihuahua 3
Domestic Longhair 2
Terrier - Jack Russell 2

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 18
Vomiting 15
Emesis (multiple) 14
Other abnormal test result NOS 12
Diarrhoea 10
Abnormal radiograph finding 9
Death 8
Weight loss 7
Death by euthanasia 7
Elevated serum alkaline phosphatase (SAP) 6
Not eating 6
Bloody diarrhoea 5

Outcome Breakdown

Ongoing
20 (31.7%)
Recovered/Normal
16 (25.4%)
Outcome Unknown
10 (15.9%)
Died
9 (14.3%)
Euthanized
7 (11.1%)
Recovered with Sequela
1 (1.6%)

Data Summary

Metric Value
Total adverse event reports 63
Reports involving death 16
Case-fatality rate (reported events) 2540.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cerenia Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 63 adverse event reports referencing Cerenia, including 16 reports in which the animal died — a 2540.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cerenia. Reported administration routes include Unknown, Subcutaneous, Oral, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cerenia reports are Dog (52 reports), Cat (11 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (7), Dog (unknown) (6), Crossbred Canine/dog (5) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cerenia are Lethargy (see also Central nervous system depression in 'Neurological') (18), Vomiting (15), Emesis (multiple) (14), Other abnormal test result NOS (12). Of the 63 reports with a coded outcome, Ongoing is the leading category at 31.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cerenia.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial